Latest filing published 04 Nov 2024 for Rocket Pharmaceuticals, INC., €47k.
Filing timeline
BuySaleInsider track record
Mark Andrew White: trading record in brief
Mark Andrew White appears in our data through filings on Rocket Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 4 April 2023 and 31 October 2024, the trades on record add up to 5 filings.
The open-market record consists of 3 sales worth €388k, with no purchase. Other entries cover 2 share grants. So far in 2024, the count stands at no purchases and 3 sales.
On 4 November 2024 came the latest disclosure, an open-market sale for €47k in Rocket Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Andrew White
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,080 shares@ US$16.62512.1% of flowCommon StockSEC:0001140361-24-045101:0
- 3,026 shares@ US$20.39514.7% of flowCommon StockSEC:0001140361-24-032761:0
- 12,532 shares@ US$24.63873.2% of flowCommon StockSEC:0001140361-24-019167:0
- 11,096 shares0Common StockSEC:0001140361-24-008887:0
- 76,662 shares0Common Stock, par value $0.01SEC:0001140361-23-018047:0
5 of 5 declarations
